Julie Krop

2017

In 2017, Julie Krop earned a total compensation of $1.3M as Chief Medical Officer and Executive Vice President, Clinical and Regulatory Affairs at AMAG Pharmaceuticals, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$194,040
Option Awards$224,392
Salary$441,885
Stock Awards$402,150
Other$8,100
Total$1,270,567

Krop received $441.9K in salary, accounting for 35% of the total pay in 2017.

Krop also received $194K in non-equity incentive plan, $224.4K in option awards, $402.2K in stock awards and $8.1K in other compensation.

Rankings

In 2017, Julie Krop's compensation ranked 7,824th out of 14,666 executives tracked by ExecPay. In other words, Krop earned more than 46.7% of executives.

ClassificationRankingPercentile
All
7,824
out of 14,666
47th
Division
Manufacturing
2,934
out of 5,768
49th
Major group
Chemicals And Allied Products
952
out of 2,074
54th
Industry group
Drugs
739
out of 1,730
57th
Industry
Pharmaceutical Preparations
578
out of 1,329
57th
Source: SEC filing on April 25, 2018.

Krop's colleagues

We found four more compensation records of executives who worked with Julie Krop at AMAG Pharmaceuticals in 2017.

2017

William Heiden

AMAG Pharmaceuticals

Chief Executive Officer

2017

Nicholas Grund

AMAG Pharmaceuticals

Chief Commercial Officer

2017

Edward Myles

AMAG Pharmaceuticals

Chief Financial Officer

2017

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

News

You may also like